探析神仙解语丹治疗缺血性中风的理论机制
Exploring the Theoretical Mechanism of ShenXian JieYu Dan in Treating Ischemic Stroke
DOI: 10.12677/TCM.2023.127244, PDF,    科研立项经费支持
作者: 刘 超：湖北中医药大学第一临床学院，湖北 武汉；夏文广*：湖北中医药大学第一临床学院，湖北 武汉；湖北中医药大学附属新华医院，湖北省中西医结合医院，湖北 武汉
关键词: 解语丹；息风化痰法；缺血性中风；JieYu Dan； Xifeng Phlegm Method； Ischemic Stroke
摘要: 本文通过对神仙解语丹的源流、配伍特点、病机进行探析，可知此方源于《妇人大全良方》，全方具有祛风化痰，行气通络开窍，内外风同治之功，主治心脾中风，痰阻廉泉，舌强不语，半身不遂。神仙解语丹，治风、痰、气、瘀各有所长，是中医治疗中风的经典方剂，其病机内涵与风痰阻络型缺血性中风的病因病机相合，故探析解语丹与缺血性中风的关系及其治疗缺血性中风的理论依据及优势，希望为后期解语丹的临床应用提供新思考。
Abstract: This article analyzes the origin, compatibility characteristics, and pathogenesis of the Shenxian Jieyu Pill. It can be concluded that this formula originates from the “Women’s Great Complete Good Formula”. The entire formula has the functions of dispelling wind and resolving phlegm, promoting qi and unblocking collaterals to open the orifices, and treating both internal and external wind simultaneously. It is mainly used to treat stroke in the heart and spleen, phlegm blocking clean springs, strong tongue without language, and hemiplegia. Shenxian Jieyu Dan has its own advantages in treating wind, phlegm, qi, and blood stasis. It is a classic formula for treating stroke in traditional Chinese medicine. Its pathogenesis is consistent with the etiology and pathogenesis of wind phlegm obstructing collaterals type ischemic stroke. Therefore, the relationship between Jieyu Dan and ischemic stroke and its theoretical basis and advantages in treating ischemic stroke are analyzed, hoping to provide new thinking for the clinical application of Jieyu Dan in the later stage.
文章引用：刘超, 夏文广. 探析神仙解语丹治疗缺血性中风的理论机制[J]. 中医学, 2023, 12(7): 1638-1641. https://doi.org/10.12677/TCM.2023.127244

参考文献

[1] Zhong, L.L., Ding, L.S., He, W., Tian, X.Y., Cao, H., Song, Y.Q., Yu, L. and Sun, X.Y. (2017) Systolic Hypertension Related Single Nucleotide Polymorphism Is Associated with Susceptibility of Ischemic Stroke. European Review for Medical and Pharmacological Sciences, 21, 2901-2906.
[2] 刘会芳, 邓君启, 王侠, 等. 化痰通络方加减治疗急性脑梗死风痰阻络证的临床效果及对患者同型半胱氨酸、D-二聚体水平的影响[J]. 临床医学研究与实践, 2022, 7(14): 118-120, 125.
[3] 陈美丽, 李赵军, 谭赛辉. 神仙解语丹治疗中风偏瘫30例临床观察[J]. 湖南中医杂志, 2014, 30(7): 37-39.
[4] Jeong, H.-G., Ko, S.-B., Kim, C.K., Kim, Y., Jung, S., Kim T.J., Yoon, B.-W. (2016) Tachycardia Burden in Stroke Unit Is Associated with Functional Outcome after Ischemic Stroke. International Journal of Stroke, 11, 313-320. [Google Scholar] [CrossRef] [PubMed]
[5] 李超然, 孙忠人, 刘德柱. 中风病古代文献探析[J]. 江苏中医药, 2017, 49(7): 70-72.
[6] 徐娜, 杨宇峰. 历代医家论中风病之因机理论框架[J]. 辽宁中医药大学学报, 2019, 21(3): 75-77.
[7] 董子源, 王长德. 缺血性中风急性期中医辨证论治的研究进展[J]. 世界中医药, 2021, 16(24): 3708-3712.
[8] 周韩, 周德生, 刘利娟, 等. 缺血中风荣气虚滞病机源流[J]. 中医学报, 2019, 34(9): 1844-1849.
[9] 温馨, 韩晓东, 刘洪敏, 黄炜, 曹小宁. 从“风痰瘀论”治疗中风与细胞自噬作用相关机制研究[J]. 中华中医药学刊, 2021, 39(12): 209-212.
[10] 刘启雄, 邱爱霞, 熊百炼. 解语丹加减联合醒脑开窍针对脑梗死恢复期肢体运动功能影响临床研究[J]. 中华中医药学刊, 2020, 38(1): 187-190.
[11] 邱富华, 王宁, 曹忠耀, 等. 解语丹加减结合项针治疗中风后失语临床疗效及其机理研究[J]. 四川中医, 2021, 39(8): 131-134.
[12] 付蕾, 毛艳华, 高远, 等. 天麻素对大鼠皮层缺氧神经细胞NR1亚基mRNA表达的影响[J]. 中国中药杂志, 2008, 33(9): 1049-1052.
[13] 许鑫, 楚世峰, 陈乃宏. 天麻素对缺血性脑卒中中血管新生的影响[J]. 中国药理学与毒理学杂志, 2018, 32(9): 679-680.
[14] 王星璐, 李慧娟, 赵伟, 等. 远志叶绿体基因组序列特征与系统发育分析[J]. 中草药, 2023, 54(11): 3655-3665.
[15] 赵璇, 王彬, 马彦江, 等. 基于主成分分析法优选半夏、天南星及白附子水丸制剂工艺[J]. 中华中医药学刊, 2023, 42(3): 85-91, 270-271.